NIH Awards U of Maryland $3.7M for Personalized Medicine Program in Monogenic Diabetes | GenomeWeb

NEW YORK (GenomeWeb) – The University of Maryland School of Medicine announced it has been awarded a four-year, $3.7 million grant from the National Institutes of Health to develop a personalized medicine program for the diagnosis and treatment of monogenic diabetes.

The National Human Genome Research Institute and the Implementing Genomics in Practice network is providing the funding for the project.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.